These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9249925)

  • 41. Placental transport and embryonic utilization of essential metabolites in the rat at the teratogenic dose of cadmium.
    Webb M; Samarawickrama GP
    J Appl Toxicol; 1981 Oct; 1(5):270-7. PubMed ID: 6193163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resistance of CD-1 and ogg1 DNA repair-deficient mice to thalidomide and hydrolysis product embryopathies in embryo culture.
    Lee CJ; Gonçalves LL; Wells PG
    Toxicol Sci; 2011 Jul; 122(1):146-56. PubMed ID: 21505090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Embryotoxicity in mice of phosphonacetyl-L-aspartic acid (PALA), a new antitumor agent. II. Studies on its mechanism and reversibility.
    Sieber SM; Botkin CC; Leslie KA; Cooney DA
    Teratology; 1980 Dec; 22(3):321-8. PubMed ID: 7233337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Embryotoxicity in chick embryo of thalidomide hydrolysis products following metabolic activation by rat liver homogenate.
    Veselá D; Veselý D; Jelínek R
    Funct Dev Morphol; 1994; 4(4):313-6. PubMed ID: 7612952
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential inhibition of protein synthesis: a possible biochemical mechanism of thalidomide teratogenesis.
    Shull GE
    J Theor Biol; 1984 Oct; 110(3):461-86. PubMed ID: 6503311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Teratologic study of a new, structurally related to thalidomide, sedative-hypnotic effective compound (K-2004)].
    Stockinger L; Koch H
    Arzneimittelforschung; 1969 Feb; 19(2):167-9. PubMed ID: 4238697
    [No Abstract]   [Full Text] [Related]  

  • 47. Responses of pre-implantation mouse embryos to thalidomide exposure in utero.
    Palayoor T; Raveendran P; Batra BK
    Indian J Exp Biol; 1976 May; 14(3):258-62. PubMed ID: 992766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of adhesion receptors on rat limb bud cells and results of treatment with a thalidomide derivative.
    Thiel R; Kastner U; Neubert R
    Life Sci; 2000; 66(2):133-41. PubMed ID: 10666009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Time periods for the realization of the embryotoxic action of cyclophosphamide and chloridin in vivo and in vitro].
    Popov VB
    Farmakol Toksikol; 1982; 45(1):79-83. PubMed ID: 7056386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological fate of [14C]-1-nitropyrene in rats following intragastric administration.
    van Bekkum YM; van den Broek PH; Scheepers PT; Noordhoek J; Bos RP
    Chem Biol Interact; 1999 Jan; 117(1):15-33. PubMed ID: 10190542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fetal cartilage malformation by intravenous administration of indium trichloride to pregnant rats.
    Nakajima M; Takahashi H; Nakazawa K; Usami M
    Reprod Toxicol; 2007; 24(3-4):409-13. PubMed ID: 17646080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The L-isomer as teratogenic principle of N-phthalyl-DL-glutamic acid].
    Ockenfels H; Köhler F
    Experientia; 1970 Nov; 26(11):1236-7. PubMed ID: 5485295
    [No Abstract]   [Full Text] [Related]  

  • 53. Development of an in vitro system detecting pro-embryotoxin.
    Miyata M; Tamura E; Yamazoe Y
    Jpn J Pharmacol; 2002 Jul; 89(3):320-3. PubMed ID: 12184740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thalidomide leads to mandible hypoplasia through inhibiting angiogenesis and secondary hemorrhage in the fetal craniofacial region in rabbits.
    Zhao Y; Chen Q; Chen L; Shen SGF; Dai J
    Toxicol Lett; 2020 Feb; 319():250-255. PubMed ID: 31778774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of thalidomide teratogenicity by acetylsalicylic acid: evidence for prostaglandin H synthase-catalyzed bioactivation of thalidomide to a teratogenic reactive intermediate.
    Arlen RR; Wells PG
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1649-58. PubMed ID: 8667234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolism and biochemical effects of 3,3',4,4'-tetrachlorobiphenyl in pregnant and fetal rats.
    Morse DC; Wehler EK; van de Pas M; de Bie AT; van Bladeren PJ; Brouwer A
    Chem Biol Interact; 1995 Mar; 95(1-2):41-56. PubMed ID: 7697753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Teratologic studies on the Himalayan rabbit: new aspects of thalidomide-induced teratogenesis.
    Sterz H; Nothdurft H; Lexa P; Ockenfels H
    Arch Toxicol; 1987 Jul; 60(5):376-81. PubMed ID: 3662810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The toxicity of niridazole in rat embryos in vitro.
    Fantel AG; Greenaway JC; Walker E; Juchau MR
    Teratology; 1986 Feb; 33(1):105-12. PubMed ID: 3738802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Teratological studies of p-butoxyphenylacethydroxamic acid (CP 1044 J3) in rats and rabbits.
    Roba J; Lambelin G; Buu-Hoï NP
    Arzneimittelforschung; 1970 Apr; 20(4):565-9. PubMed ID: 5467822
    [No Abstract]   [Full Text] [Related]  

  • 60. [Chromatographic separation of racemic thalidomide and teratogenic activity of its enantiomers (author's transl)].
    Blaschke G; Kraft HP; Fickentscher K; Köhler F
    Arzneimittelforschung; 1979; 29(10):1640-2. PubMed ID: 583234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.